Fluxome Appoints Tsetsis as New CEO
Fluxome has appointed senior executive Mrs. Angela Tsetsis as the new CEO of the Danish nutraceutical ingredient provider. Mrs. Tsetsis brings more than 25 years of international sales, marketing and business development experience in the nutritional and food ingredient industry.
4 April 2012 --- Fluxome has appointed former Vice President of Martek/DSM, Angela Tsetsis, as its new CEO. She brings more than 25 years of experience from the nutritional and food ingredient industry and will be responsible for continuing the positive development of the company with the aim of becoming the leading global provider of resveratrol as well as a key player in the nutraceutical ingredient industry.
Fluxome has appointed senior executive Mrs. Angela Tsetsis as the new CEO of the Danish nutraceutical ingredient provider. Mrs. Tsetsis brings more than 25 years of international sales, marketing and business development experience in the nutritional and food ingredient industry. She was among the key individuals to transform the successful ingredient company Martek (now part of Royal DSM) from a small entrepreneurial company to a leading global company with a turnover of close to USD 500 M. In her latest role she took up the position as VP, Corporate Strategy, with a broad responsibility for all commercial business units.
With Mrs. Tsetsis' global experience in bringing innovative products to the market along with her ability to utilize cutting edge fermentation technologies she is set to build on Fluxome's existing platform, accelerate growth in sales of existing products such as Fluxome Resveratrol, and commercialize the promising product pipeline in Fluxome.
The new CEO states "I am ready to take Fluxome to the next level and utilize the massive potential of one of the most promising and innovative companies in the nutraceutical ingredient industry". She continues "I am confident that Fluxome can become the leading company in the resveratrol market and a key player in the nutraceutical industry over time".
Fluxome is already in the process of penetrating the US market and has just launched Fluxome Resveratrol in Europe after obtaining Novel Foods Approval. Jarne Elleholm, Chairman of the Board is excited to bring the new CEO on board "Angela Tsetsis is the perfect match for Fluxome. In the past she has proven how she is able to play a central role in growing a company to become a world-leading player in the nutraceutical arena".
Angela Tsetsis, a US citizen, not only has a substantial knowledge of the US market but also offers extensive international experience. "We are lucky to welcome a sharp-minded executive who has both skills and visions to continue the global expansion of our company - but also the entrepreneurial mindset and determination required to utilize the potential of our technology platform" Mr. Elleholm reassures.
Although Fluxome is not yet a dominating force in the industry they do not lack the ambitions to make a difference in the nutraceutical world. Angela Tsetsis states "It is incredible to see how a relatively young company like Fluxome is already making a difference in the industry by setting new high standards for product quality and I am eager to further explore the untapped potential of the resveratrol market". She adds "This market definitely has all the potential to become one of the most interesting ones to follow this decade".
Fluxome Resveratrol is a novel source of pure natural resveratrol produced by a patented and sustainable fermentation process. The product consistently exceeds a purity level of 98% trans-resveratrol and is completely free of contaminants such as heavy metals and pesticide residues. The production method ensures a very reliable source of resveratrol and the opportunity to deliver consistent high batch-to-batch quality.
Fluxome is a leader in producing nutraceutical ingredients by natural, eco-friendly fermentation technologies that utilize novel bioprocesses. Fluxome's pipeline includes vegetarian omega-3 and omega-6 fatty acids produced by fermentation.
